Dyve Biosciences and Moffitt Cancer Center Report Promising Study Results for First-of-Its-Kind Topical Therapy Targeting Tumor Acidity Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and…
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult…
Lineage Announces Formation of Scientific Advisory Board Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the formation of a Scientific Advisory Board (SAB) to provide…
AdaptHealth Refinances Credit Facility, Extends Maturity and Lowers Debt Costs AdaptHealth Corp., a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that it has closed a $1.1 billion senior secured…
Johnson & Johnson Presents New TECNIS PureSee IOL Clinical Data Showing Strong Contrast Sensitivity and Extended Vision Range at ASCRS 2026 Johnson & Johnson (NYSE: JNJ) has announced the presentation of new clinical and real-world data supporting the performance of…
New Billboards Highlight AHF as a Leading HIV Care Provider and Encourage STD Testing AIDS Healthcare Foundation (AHF), one of the largest nonprofit providers of HIV/AIDS care in the world, has unveiled two new nationwide billboard and outdoor advertising campaigns…
Charles River Promotes Cardiovascular Health Awareness with Support for the American Heart Association Charles River Laboratories International, Inc. (NYSE: CRL) has announced a new collaboration with the American Heart Association, a globally recognized leader in advancing heart and brain health.…
Emalex Awarded U.S. Patent for Its Orally Disintegrating Ecopipam Formulation Emalex Biosciences has announced a significant advancement in its drug development efforts with the issuance of a new patent by the U.S. Patent and Trademark Office. The patent covers an…
Cartherics and Catalent Extend Scope of Existing Commercial Licensing Agreement Cartherics Pty Ltd, a clinical-stage biotechnology company focused on developing next-generation immune cell therapies for high-impact women’s health conditions, has announced an expanded strategic partnership with Catalent, Inc., a global…
Virica Biotech and FUJIFILM Biosciences Team Up to Advance AAV Production Enhancers Through Canada–Japan Co-Innovation Initiative Virica Biotech, a biotechnology firm focused on improving viral vector manufacturing through its proprietary Viral Sensitizer Enhancer (VSE™) technology, has announced a new international…
Adagio Medical Secures U.S. Food and Drug Administration IDE Approval to Study Its Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio”), a medical technology company focused on advancing catheter-based ablation solutions for cardiac arrhythmias, has announced…
Sidewinder Therapeutics Secures $137 Million Series B to Advance Precision Bispecific ADCs into Clinical Development for Cancer Sidewinder Therapeutics, a biopharmaceutical company focused on advancing next-generation antibody-drug conjugates (ADCs) for oncology, has announced the successful closing of an oversubscribed $137…